Page 3 - Master Files News Today

Frederick, MD (PRWEB) October 25, 2022 -- FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy,...

Frederick, MD (PRWEB) August 30, 2022 -- RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and

Frederick, MD (PRWEB) August 18, 2022 -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO),

Investegate announcements from AGC Biologics, RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies

New partnership delivers clinically proven products and manufacturing processes for advanced therapies...

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 24, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New

RANCHO CUCAMONGA, CA / ACCESSWIRE / April 8, 2022 / Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New

Biosimilars are large, complex molecules with high similarity to an existing and licensed biotherapeutic product, developed for use when the current patent comes to an end. In recent years, biosimilars have led to more accessible treatment for a large variety of diseases due to more competitive pricing and greater accessibility for a large variety of diseases.

Reports Net Revenues of $120.9 Million for the Three Months Ended December 31, 2021RANCHO CUCAMONGA, CA / ACCESSWIRE / March 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the